The Bioinformatics Core was created to provide and build bioinformatics services and infrastructure for the MSKCC research community. The services of the core include scientific consultations, high performance computing and high capacity data storage support, training via clinics and workshops, custom programming on both small and large scale software projects, and pipelines for data analysis. The Core has grown to 13 full time staff members including PhD level research scientists and a professional staff of engineers, programmers and systems administrators. The Core provides all levels of bioinformatics support from small scale script writing to long term analytic support. As new technologies emerge, such as next-generation sequencing, the Core's focus and services have grown to meet them. The broad range of services and collaborative work provided by the Bioinformatics Core has supported the research of 66 investigators in the past year. During the past grant period the work of the Core has contributed to 365 publications of researchers from 8 research programs. For example, the Core supported Drs. Sawyers, Gerald, and Sander in the analysis of genomic datasets generated by the MSKCC Genomics Core from 214 primary and metastatic prostate cancer samples that were obtained from the MSKCC Pathology Core. The Core developed the informatics pipeline for analysis of exon resequencing data, generated plots of copy number alterations from array CGH data, and conducted preliminary analyses of the mRNA transcriptome and microRNA expression data from arrays run by the Genomics Core. This work led to the first comprehensive integrated genomic analysis of prostate cancer and has served as a key source of information for the field since its publication in 2010.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA008748-48
Application #
8933565
Study Section
Subcommittee G - Education (NCI)
Program Officer
Shafik, Hasnaa
Project Start
2014-01-01
Project End
2018-12-31
Budget Start
2014-01-01
Budget End
2014-12-31
Support Year
48
Fiscal Year
2014
Total Cost
$860,681
Indirect Cost
$376,336
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Orlow, I; Satagopan, J M; Berwick, M et al. (2015) Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC). Br J Dermatol 172:1081-9
Carey, Bryce W; Finley, Lydia W S; Cross, Justin R et al. (2015) Intracellular ?-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature 518:413-6
Mosher, C E; Given, B A; Ostroff, J S (2015) Barriers to mental health service use among distressed family caregivers of lung cancer patients. Eur J Cancer Care (Engl) 24:50-9
Navi, Babak B; Reiner, Anne S; Kamel, Hooman et al. (2015) Association between incident cancer and subsequent stroke. Ann Neurol 77:291-300
Xu, Zhe; Wu, Chaochao; Xie, Fang et al. (2015) Comprehensive quantitative analysis of ovarian and breast cancer tumor peptidomes. J Proteome Res 14:422-33
Xu, Hong; Cheng, Ming; Guo, Hongfen et al. (2015) Retargeting T cells to GD2 pentasaccharide on human tumors using Bispecific humanized antibody. Cancer Immunol Res 3:266-77
Gondo, Tatsuo; Poon, Bing Ying; Matsumoto, Kazuhiro et al. (2015) Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer. BJU Int 115:81-6
Lu, Zhigang; Xu, Jin; Xu, Mingming et al. (2014) Morphine regulates expression of *-opioid receptor MOR-1A, an intron-retention carboxyl terminal splice variant of the *-opioid receptor (OPRM1) gene via miR-103/miR-107. Mol Pharmacol 85:368-80
Kaittanis, Charalambos; Shaffer, Travis M; Thorek, Daniel L J et al. (2014) Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy. Crit Rev Oncog 19:143-76
Das, Sudeep; Thorek, Daniel L J; Grimm, Jan (2014) Cerenkov imaging. Adv Cancer Res 124:213-34

Showing the most recent 10 out of 836 publications